Canine mammary cancers have been histopathologically and clinically subtyped, as well as molecularly subtyped with immunohistochemical markers established for human breast cancer (anti-ER, PR, HER2, -CK 5/6 and -CK14) [19, 20, 23, 24]. This evidence concerns the gene KRT14 and breast cancer.